(19)
(11) EP 4 770 663 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24860406.8

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
A61K 38/46(2006.01)
A61K 9/08(2006.01)
A61K 47/30(2006.01)
 A61K 9/00(2006.01)
A61K 47/26(2006.01)
A61P 25/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 43/00; A61K 47/26; A61P 25/00; A61P 25/28; A61K 9/08; A61K 9/0019; A61K 9/0085; A61K 38/47; C12Y 302/0105; A61K 31/727
 
C-Sets:
A61K 38/47, A61K 2300/00;
(86) International application number:
PCT/KR2024/012852
(87) International publication number:
WO 2025/048486 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.08.2023 KR 20230112883

(71) Applicant: GREEN CROSS CORPORATION
Yongin-si, Gyeonggi-do 16924 (KR)

(72) Inventors:
  • KIM, So Ra
    Yongin-si Gyeonggi-do 16924 (KR)
  • KIM, Minju
    Yongin-si Gyeonggi-do 16924 (KR)
  • JIN, Dong Kyu
    Seoul 06293 (KR)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) COMPOSITION FOR THE TREATMENT OF SANFILIPPO SYNDROME TYPE A (MPS IIIA) COMPRISING HEPARAN N-SULFATASE (HNS)